Louis  Kayitalire net worth and biography

Louis Kayitalire Biography and Net Worth

Dr. Kayitalire brings over 20 years’ experience in oncology and immuno-oncology, joining F-star in June 2019 from Bristol-Myers Squibb where he was responsible for the clinical research strategy for broad development of oncology assets and advancing clinical research efforts with a team of medical directors from March 2016 to June 2019. Prior to that, Dr. Kayitalire held senior positions at major pharmaceutical companies including Celgene from September 2013 to March 2016. Dr. Kayitalire completed his medical training at Butare University, Rwanda and later as Assistant Professor in Oncology at the Paris XI University of France. He is an active member of the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).

How do I contact Louis Kayitalire?

The corporate mailing address for Dr. Kayitalire and other F-star Therapeutics executives is 35 PARKWOOD DRIVE SUITE 210, HOPKINTON MA, 01748. F-star Therapeutics can also be reached via phone at 441223497400 and via email at [email protected]. Learn More on Louis Kayitalire's contact information.

Has Louis Kayitalire been buying or selling shares of F-star Therapeutics?

Louis Kayitalire has not been actively trading shares of F-star Therapeutics during the last quarter. Most recently, Louis Kayitalire sold 64 shares of the business's stock in a transaction on Tuesday, November 2nd. The shares were sold at an average price of $6.83, for a transaction totalling $437.12. Learn More on Louis Kayitalire's trading history.

Louis Kayitalire Insider Trading History at F-star Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/2/2021Sell64$6.83$437.12View SEC Filing Icon  
10/4/2021Sell64$7.23$462.72View SEC Filing Icon  
7/2/2021Sell1,054$8.43$8,885.22View SEC Filing Icon  
See Full Table

Louis Kayitalire Buying and Selling Activity at F-star Therapeutics

This chart shows Louis Kayitalire's buying and selling at F-star Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

F-star Therapeutics Company Overview

F-star Therapeutics logo
F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom.
Read More

Today's Range

Now: $7.12
Low: $7.12
High: $7.12

50 Day Range

MA: $6.19
Low: $4.42
High: $7.12

2 Week Range

Now: $7.12
Low: $2.07
High: $7.12

Volume

N/A

Average Volume

709,213 shs

Market Capitalization

$156.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85